CATEGORIES

Editors Choice

LATEST

TRENDING

EDITORS CHOICE

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

Dense Breasts: The Hidden Risk You Can’t Ignore

You learn you have dense breasts. Now what?

Purpose at the Center: Craig Martin’s “Rare” Commitment to Biopharma and Patients

Craig Martin is a strategic chameleon in health innovation. He is equally at home in boardrooms, nonprofit leadership, consulting and advisory roles, all with...

One in Five With Adult Covid Develop Long COVID

Many with COVID get lasting health problems in many different organ systems, including the heart, lungs, and kidneys.